Background illustration for clinical trials search

Paid Clinical Trials Birmingham

Discover 907 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

Migraine Prevention Studies for Adults With 2–10 Moderate-to-Severe Attacks a Month

for
Migraine Disorders
Location: Birmingham AL, Anderson SC, Gaffney SC, Savannah GA,

Sex: All

Age: 18 - 70+

Recruiting
FeaturedActive & Responsive

Diabetic Nerve Pain Study of a Non-Opioid Medication for Adults With Ongoing Foot and Leg Pain

for
Diabetic Neuropathies
Location: Birmingham AL, Anderson SC, Gulfport MS, Spartanburg SC,

Sex: All

Age: 18 - 70+

Recruiting
FeaturedActive & Responsive

Cardiovascular Disease Studies for Adults With High Blood Pressure, High Cholesterol, AFib, or Heart Failure

for
Cardiovascular Diseases, Heart Failure, Atrial Fibrillation,
Location: Birmingham AL, Columbus GA, Mauldin SC, Union SC,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

for
Influenza
Location: Birmingham AL, Harrisburg AR, Bardstown KY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 0 - 11

Code: NCT06094010

Phase 3, Recruiting
Featured

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Birmingham AL, Mobile AL, Jackson MS, Covington LA,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

for
Mature B-Cell Non-Hodgkin Lymphoma
Location: Birmingham AL, Cincinnati OH, Kansas City MO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 0 - 30

Code: NCT05533775

Phase 1, Phase 2, Recruiting
Featured

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

for
Non-cystic Fibrosis Bronchiectasis,
Location: Birmingham AL, Chapel Hill NC, Kansas City KS,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06603246

Phase 1, Recruiting
Featured

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

for
Obesity or Overweight
Location: Birmingham AL, Anniston AL, Union City GA, Nashville TN,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351045

Phase 3, Recruiting
Featured

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis
Location: Birmingham AL, Dothan AL, Champaign IL, Kissimmee FL,
Sponsor: AbbVie

Sex: All

Age: 40+

Code: NCT07230288

Phase 2, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Birmingham AL, Atlanta GA, Nashville TN, Memphis TN,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase 3, Recruiting
Featured

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

for
Alzheimers Disease
Location: Birmingham AL, Columbus GA, Atlanta GA, Decatur GA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07177352

Phase 3, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Birmingham AL, Marietta GA, Atlanta GA, Nashville TN,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase 3, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Birmingham AL, Marietta GA, Dalton GA, Chattanooga TN,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase 3, Recruiting
Featured

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Birmingham AL, Newnan GA, Nashville TN, Memphis TN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07365241

Phase 3, Recruiting
Featured

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Pelham AL, Nashville TN, Knoxville TN, Fayette MS,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase 2, Recruiting
Featured

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

for
Systemic Lupus Erythematosus, Rheumatoid Arthritis
Location: Anniston AL, Jackson TN, Clearwater FL, Tampa FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07607964

Phase 1, Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Birmingham AL, Nashville TN, Louisville KY,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

for
Phelan-McDermid Syndrome
Location: Birmingham AL, Atlanta GA, Cincinnati OH, Columbus OH,
Sponsor: Neuren Pharmaceuticals Limited

Sex: All

Age: 3 - 12

Code: NCT07281079

Phase 3, Recruiting
Active & Responsive

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: Birmingham AL, Nashville TN, Lexington KY, Charlotte NC,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05722418

Phase 1, Recruiting
Active & Responsive

Ketogenic Diets for Weight Loss Maintenance: Impact on Energy Expenditure and Appetite in Individuals With Obesity

for
Obesity
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 65

Code: NCT06736028

Recruiting